Web1 dag geleden · As part of our focus on cancer, Merck is committed to exploring the potential of immuno-oncology with one of the largest development programs in the industry across more than 30 tumor types. We also continue to strengthen our portfolio through strategic acquisitions and are prioritizing the development of several promising oncology … WebOut-Licensed Oncology & Autoimmune Disease Pipeline *. * Information in pipeline chart current as of January 2024. (1) Late stage refers to active Phase IIb clinical trials or more …
Individualized neoantigen therapies: exploring one medicine
Web8 sep. 2024 · The products under the company’s Oncology segment include Kyprolis, Blincyto, Vectibix, Kanjinti, Mvasi, Xgeva, Neulasta, Neupogen, Lumakras, and Sensipar. … Web19 nov. 2024 · As part of Merck’s oncology pipeline, our lead product candidate, VLS-101, is now well positioned to achieve its maximum potential to benefit appropriate cancer … homes for sale hampton ct
Merck to Acquire Peloton Therapeutics, Bolstering Oncology Pipeline
Web3 jun. 2024 · Merck KGaA, Darmstadt, Germany today provided an update on the progress of the company’s innovative oncology development pipeline focused on DNA damage … Web7 sep. 2024 · DARMSTADT, Germany--(BUSINESS WIRE)--Merck, a leading science and technology company, today announced the latest research from the Company’s … Web30 sep. 2024 · Adam Zamecnik. Credits: Shutterstock / nito. Last week, Merck & Co announced it is discontinuing a program to study monthly oral doses of islatravir as pre … homes for sale hampton county sc